Dermatology

Expanded FDA clearance granted for Smoothbeam

Published in Biotech Business Week, October 13th, 2003

Candela Corporation (CLZR) announced that it has received expanded wrinkle clearance from the U. S. Food and Drug Administration (FDA) to market its Smoothbeam diode laser for the non-invasive treatment of wrinkles on the face.

Gerard E. Puorro, Candela's president and CEO, commented: "We are very pleased to gain this additional clearance from the FDA. The treatment of wrinkles and other cosmetic procedures is growing at a tremendous rate. Our involvement in these markets outlines our path for growth in the coming years. This represents our fourth FDA approval for Smoothbeam. Adding multiple indications to our lasers makes purchasing a laser an attractive financial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2003-10-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry